Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2010

01-04-2010 | Research Article

Clinical pharmacists’ interventions in a German University Hospital

Authors: Claudia Langebrake, Heike Hilgarth

Published in: International Journal of Clinical Pharmacy | Issue 2/2010

Login to get access

Abstract

Objective To evaluate pharmaceutical interventions by ward-based clinical pharmacists in Germany. Setting Two ward-based clinical pharmacists working at the Departments of Stem Cell Transplantation and Intensive Care Medicine. Methods Pharmaceutical interventions during ward rounds from December 1st 2006 to November 30th 2008 were recorded and classified according to our own system that was adopted from established classification systems. Main outcome measure Classification of (1) cause of intervention, (2) intervention, (3) outcome of intervention and (4) initiator of intervention. Results Altogether 2,312 interventions were documented. Besides 520 cases of information about drugs (rational selection, occurrence of infrequent adverse events or interactions), the main interventions were recommendations for the addition, the withdrawal or the replacement of a drug (n = 907, 50.6%) and advices for the change of dosage, dosing intervals or dose adjustment according to impaired renal or liver function (n = 584, 32.6%). The vast majority of the suggested interventions (92.8%) have been accepted. Conclusion The participation of a clinical pharmacist during ward rounds contributes to the optimisation of pharmacotherapy, in terms of choosing the most appropriate drug and/or the suitable dosage and may improve patient care.
Literature
1.
go back to reference Surugue J, Vulto AG. Workforce of EU hospitals and pharmacy services: a direct patient safety issue. EJHP Pract. 2006;12:31–3. Surugue J, Vulto AG. Workforce of EU hospitals and pharmacy services: a direct patient safety issue. EJHP Pract. 2006;12:31–3.
2.
go back to reference Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166:955–64.CrossRefPubMed Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166:955–64.CrossRefPubMed
3.
go back to reference Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102:275–80.CrossRefPubMed Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102:275–80.CrossRefPubMed
4.
go back to reference Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014–8.CrossRefPubMed Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014–8.CrossRefPubMed
5.
go back to reference Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.CrossRefPubMed Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.CrossRefPubMed
6.
go back to reference Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherapy. 2006;26:735–47.CrossRefPubMed Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherapy. 2006;26:735–47.CrossRefPubMed
7.
go back to reference Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27:481–93.CrossRefPubMed Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27:481–93.CrossRefPubMed
8.
go back to reference Phansalkar S, Hoffman JM, Nebeker JR, Hurdle JF. Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. Am J Health Syst Pharm. 2007;64:842–9.CrossRefPubMed Phansalkar S, Hoffman JM, Nebeker JR, Hurdle JF. Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. Am J Health Syst Pharm. 2007;64:842–9.CrossRefPubMed
9.
go back to reference Tonna AP, Stewart D, West B, Gould I, McCaig D. Antimicrobial optimisation in secondary care: the pharmacist as part of a multidisciplinary antimicrobial programme—a literature review. Int J Antimicrob Agents. 2008;31:511–7.CrossRefPubMed Tonna AP, Stewart D, West B, Gould I, McCaig D. Antimicrobial optimisation in secondary care: the pharmacist as part of a multidisciplinary antimicrobial programme—a literature review. Int J Antimicrob Agents. 2008;31:511–7.CrossRefPubMed
10.
go back to reference Heyde C, Rutsch A, Eschke D. Clinical pharmacists increase the safety of drug therapy at the time of admission. Krankenhauspharmazie. 2009;30:215–7. Heyde C, Rutsch A, Eschke D. Clinical pharmacists increase the safety of drug therapy at the time of admission. Krankenhauspharmazie. 2009;30:215–7.
11.
go back to reference Walk SU, Fritz S, Pruszydlo MG, Hartwig W, Haefeli WE, Hoppe-Tichy T. Pharmaceutical counselling of drug switches at the interface between primary and tertiary care. Krankenhauspharmazie. 2009;30:218–21. Walk SU, Fritz S, Pruszydlo MG, Hartwig W, Haefeli WE, Hoppe-Tichy T. Pharmaceutical counselling of drug switches at the interface between primary and tertiary care. Krankenhauspharmazie. 2009;30:218–21.
12.
go back to reference Frey OR. Therapeutic drug monitoring. Krankenhauspharmazie. 2009;30:222–4. Frey OR. Therapeutic drug monitoring. Krankenhauspharmazie. 2009;30:222–4.
13.
go back to reference Hartmann A, Eberhardt T, Brüggmann J. Dose individualization in patients with renal insufficiency. Krankenhauspharmazie. 2009;30:225–9. Hartmann A, Eberhardt T, Brüggmann J. Dose individualization in patients with renal insufficiency. Krankenhauspharmazie. 2009;30:225–9.
14.
go back to reference Krämer I. Pharmacist-conducted patient education and compliance enhancement in specific patient groups. Krankenhauspharmazie. 2009;30:230–5. Krämer I. Pharmacist-conducted patient education and compliance enhancement in specific patient groups. Krankenhauspharmazie. 2009;30:230–5.
15.
go back to reference Sattler A. Pharmaceutical care with SOAP-notes. Krankenhauspharmazie. 2009;30:239–41. Sattler A. Pharmaceutical care with SOAP-notes. Krankenhauspharmazie. 2009;30:239–41.
16.
go back to reference Probst W. Benefit of pharmaceutical care in patients feeded via enteral tube. Krankenhauspharmazie. 2009;30:248–50. Probst W. Benefit of pharmaceutical care in patients feeded via enteral tube. Krankenhauspharmazie. 2009;30:248–50.
17.
go back to reference Neubauer W, Hug MJ, Bertz H, Strehl E, Engelhardt M. The role of the pharmacist in the development of clinical guidelines. Krankenhauspharmazie. 2009;30:255–8. Neubauer W, Hug MJ, Bertz H, Strehl E, Engelhardt M. The role of the pharmacist in the development of clinical guidelines. Krankenhauspharmazie. 2009;30:255–8.
18.
go back to reference Rudis MI, Brandl KM. Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit Care Med. 2000;28:3746–50.CrossRefPubMed Rudis MI, Brandl KM. Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit Care Med. 2000;28:3746–50.CrossRefPubMed
19.
go back to reference Langebrake C, Hilgarth H. Clinical pharmacy at the University Medical Centre Hamburg-Eppendorf. Krankenhauspharmazie. 2008;29:83–9. Langebrake C, Hilgarth H. Clinical pharmacy at the University Medical Centre Hamburg-Eppendorf. Krankenhauspharmazie. 2008;29:83–9.
21.
go back to reference Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci. 2002;24:120–7.CrossRefPubMed Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci. 2002;24:120–7.CrossRefPubMed
22.
go back to reference Krahenbuhl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krahenbuhl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30:379–407.CrossRefPubMed Krahenbuhl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krahenbuhl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30:379–407.CrossRefPubMed
23.
go back to reference Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol. 2002;58:285–91.CrossRefPubMed Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol. 2002;58:285–91.CrossRefPubMed
24.
go back to reference Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008;168:687–94.CrossRefPubMed Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008;168:687–94.CrossRefPubMed
25.
go back to reference Falconnier AD, Haefeli WE, Schoenenberger RA, Surber C, Martin-Facklam M. Drug dosage in patients with renal failure optimized by immediate concurrent feedback. J Gen Intern Med. 2001;16:369–75.CrossRefPubMed Falconnier AD, Haefeli WE, Schoenenberger RA, Surber C, Martin-Facklam M. Drug dosage in patients with renal failure optimized by immediate concurrent feedback. J Gen Intern Med. 2001;16:369–75.CrossRefPubMed
26.
go back to reference Bond CA, Raehl CL. Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients. Am J Health Syst Pharm. 2007;64:1935–42.CrossRefPubMed Bond CA, Raehl CL. Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients. Am J Health Syst Pharm. 2007;64:1935–42.CrossRefPubMed
27.
go back to reference Klopfer JD, Einarson TR. Acceptance of pharmacists’ suggestions by prescribers: a literature review. Hosp Pharm. 1990;25:830–6.PubMed Klopfer JD, Einarson TR. Acceptance of pharmacists’ suggestions by prescribers: a literature review. Hosp Pharm. 1990;25:830–6.PubMed
28.
go back to reference Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy. 2003;23:113–32.CrossRefPubMed Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy. 2003;23:113–32.CrossRefPubMed
29.
go back to reference Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy. 2002;22:134–47.CrossRefPubMed Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy. 2002;22:134–47.CrossRefPubMed
30.
go back to reference Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29:691–8.PubMed Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29:691–8.PubMed
31.
go back to reference Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007;64:2483–7.CrossRefPubMed Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007;64:2483–7.CrossRefPubMed
32.
go back to reference Kantelhardt P, Langebrake C. DokuPIK—a new database for the documentation of medication errors and pharmaceutical interventions (part I medication errors). Krankenhauspharmazie. 2009;30:63–8. Kantelhardt P, Langebrake C. DokuPIK—a new database for the documentation of medication errors and pharmaceutical interventions (part I medication errors). Krankenhauspharmazie. 2009;30:63–8.
33.
go back to reference Langebrake C, Kantelhardt P. DokuPIK—a new database for the documentation of medication errors and pharmaceutical interventions (part II interventions). Krankenhauspharmazie. 2009;30:149–55. Langebrake C, Kantelhardt P. DokuPIK—a new database for the documentation of medication errors and pharmaceutical interventions (part II interventions). Krankenhauspharmazie. 2009;30:149–55.
Metadata
Title
Clinical pharmacists’ interventions in a German University Hospital
Authors
Claudia Langebrake
Heike Hilgarth
Publication date
01-04-2010
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 2/2010
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-010-9367-z

Other articles of this Issue 2/2010

International Journal of Clinical Pharmacy 2/2010 Go to the issue